Symbols

LLY

Eli Lilly·NYSE

--(--)

Signals Analysis

Bullish signal 4

Bearish signal 1

Consensus Rating "Buy"

EPS Beats Expectation

Price Hits New High

Low Beta

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About LLY

Eli Lilly And Company

A global pharmaceutical leader with a diverse portfolio of innovative medicines and treatments for various diseases and conditions

Industry

Pharmaceutical

Established Date

Listing Date

07/09/1970

Exchange

New York Stock Exchange

Full-time Employees

50,000

Fiscal Year Ends

12-31

Website

www.lilly.com

Security Type

Common stock

Office address

Lilly Corporate Center, Indianapolis, Indiana 46285

Business

Drug production and sales

Introduction

Incorporated in Indiana in 1901, Eli Lilly built on a drug manufacturing enterprise founded by Colonel Eli Lilly in Indianapolis in 1876. The company focuses on discovering, developing, manufacturing and marketing human pharmaceutical products. Its purpose is to combine care and discovery to create medicines that improve life around the world. Long-term success depends on the ability to continuously discover or acquire, develop and commercialize innovative medicines. The company manufactures and distributes products through factories in the United States, including Puerto Rico, as well as in Europe and Asia, with product sales in about 90 countries.

Company Financials

EPS

LLY has released its 2025 Q4 earnings. EPS was reported at 7.54, versus the expected 7.2, beating expectations. The chart below visualizes how LLY has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

LLY has released its 2025 Q4 earnings report, with revenue of 19.29B, reflecting a YoY change of 42.56%, and net profit of 6.64B, showing a YoY change of 50.48%. The Sankey diagram below clearly presents LLY's revenue sources and cost distribution.